JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC – Get Free Report) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 100 shares, a drop of 94.1% from the October 31st total of 1,700 shares. Based on an average daily volume of 500 shares, the short-interest ratio is presently 0.2 days.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in JPMorgan Healthcare Leaders ETF stock. Ignite Planners LLC bought a new position in shares of JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 3,942 shares of the company’s stock, valued at approximately $230,000. Ignite Planners LLC owned 3.03% of JPMorgan Healthcare Leaders ETF as of its most recent SEC filing.
JPMorgan Healthcare Leaders ETF Price Performance
Shares of JDOC traded up $0.31 during trading hours on Wednesday, reaching $57.23. 202 shares of the company’s stock traded hands, compared to its average volume of 599. The business’s fifty day simple moving average is $58.84 and its two-hundred day simple moving average is $59.44. The firm has a market capitalization of $7.44 million, a price-to-earnings ratio of 27.37 and a beta of 0.61. JPMorgan Healthcare Leaders ETF has a twelve month low of $50.38 and a twelve month high of $63.49.
JPMorgan Healthcare Leaders ETF Company Profile
The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation.
Recommended Stories
- Five stocks we like better than JPMorgan Healthcare Leaders ETF
- The 3 Best Blue-Chip Stocks to Buy Now
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Why Are These Companies Considered Blue Chips?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Where to Find Earnings Call Transcripts
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for JPMorgan Healthcare Leaders ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Healthcare Leaders ETF and related companies with MarketBeat.com's FREE daily email newsletter.